Biliary Cancer Completed Phase 2 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0038607 (Biliary Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00948935Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract AdenocarcinomaTreatment
NCT01661114A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary CancersTreatment